INVOKANA
- Product NDC
- 50090-5033
- 11-digit product format
- 500905033
- Labeler code
- 50090
- Product ID
- 50090-5033_efb00e24-451f-4476-bd47-c2e7bdcfbf45
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- canagliflozin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA204042
- Marketing category
- NDA
- Marketing start
- 2013-03-29
- Marketing end
- 0000-00-00
- Substance
- CANAGLIFLOZIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5033-0 | 50090503300 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5033-0) | 2020-05-01 | 0000-00-00 | No | No | Current |
| 50090-5033-1 | 50090503301 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-5033-1) | 2020-05-05 | 0000-00-00 | No | No | Current |